Liquidia CORP Form 4 insider transactions
NASDAQ
LQDA
Liquidia CORPDavid Edward Johnson, a director and 10% owner of Liquidia Corp, reports the acquisition of restricted stock units convertible to common stock.
NASDAQ
LQDA
Liquidia CORPDirector Joanna Horobin reports acquisition of 20,359 shares of Liquidia Corp common stock through restricted stock units.
NASDAQ
LQDA
Liquidia CORPDirector Damian deGoa acquired 20,359 shares of Liquidia Corp common stock on June 20, 2024, as part of a restricted stock unit grant.
NASDAQ
LQDA
Liquidia CORPDirector Stephen M. Bloch acquired 20,359 shares of Liquidia Corp common stock on June 20, 2024, through restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's CFO, Michael Kaseta, reports the vesting and sale of restricted stock units (RSUs) and common stock transactions.
NASDAQ
LQDA
Liquidia CORPChief Business Officer Jason Adair of Liquidia Corp reports the vesting and sale of common stock to cover taxes.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's General Counsel, Russell Schundler, reports acquisition and disposal of company stock, including transactions to cover taxes on vested RSUs.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Commercial Officer, Scott Moomaw, reports the vesting and subsequent sale of common stock to cover taxes, alongside other holdings.
NASDAQ
LQDA
Liquidia CORPRajeev Saggar, Chief Medical Officer of Liquidia Corp, reports selling 1,649 shares of common stock on April 19, 2024, to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPRussell Schundler, General Counsel of Liquidia Corp, sold 2,060 shares of common stock on April 12, 2024, to cover taxes associated with the settlement of RSUs.
NASDAQ
LQDA
Liquidia CORPRajeev Saggar, Chief Medical Officer of Liquidia Corp, reports selling 1,525 shares of common stock to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Commercial Officer, Scott Moomaw, sold 1,585 shares of common stock on April 12, 2024, to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's CFO, Michael Kaseta, sold 3,136 shares of common stock on April 12, 2024, to cover taxes associated with the settlement of RSUs.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's CEO, Roger Jeffs, sold 8,360 shares of common stock on April 12, 2024, to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Business Officer, Jason Adair, reports the vesting and sale of company stock, including transactions made under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
LQDA
Liquidia CORPJason Adair, Chief Business Officer of Liquidia Corp, reports the vesting and sale of restricted stock units (RSUs) and common stock transactions.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's General Counsel, Russell Schundler, reports acquisition and disposal of common stock and restricted stock units (RSUs).
NASDAQ
LQDA
Liquidia CORPScott Moomaw, Chief Commercial Officer of Liquidia Corp, sold shares of common stock on March 18, 2024, to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's CFO, Michael Kaseta, reported the sale of common stock to cover taxes associated with the vesting of Restricted Stock Units (RSUs).
NASDAQ
LQDA
Liquidia CORPRajeev Saggar, Chief Medical Officer of Liquidia Corp, sold shares of common stock on March 18, 2024, to cover tax obligations related to the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp CEO Roger Jeffs sold shares to cover taxes related to the settlement of restricted stock units, according to a recent SEC filing.
NASDAQ
LQDA
Liquidia CORPChief Commercial Officer Scott Moomaw reports the vesting and sale of Liquidia Corp stock to cover taxes.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Business Officer, Jason Adair, reports the vesting and sale of restricted stock units (RSUs) to cover taxes, along with other holdings.